Stock 2162 KEYMED BIOSCIENCES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Keymed Biosciences Inc.

Equities

2162

KYG5252B1023

Biotechnology & Medical Research

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:20 2024-04-26 am EDT 		5-day change 1st Jan Change
34.9 HKD -0.14% Intraday chart for Keymed Biosciences Inc. +27.14% -28.92%
Apr. 12 Keymed Biosciences Advances Solid Tumors Drug With First Patient Study MT
Mar. 27 KeyMed Biosciences’ Attributable Loss Widens in 2023 MT

Business Summary

Keymed Biosciences Inc is a China-based biotechnology company. The Company focuses on the independent discovery and development of innovative biological therapies that address underserved medical needs in the autoimmune and oncology therapeutic areas. The Company has mastered in-house drug discovery and development technologies, including an innovative antibody discovery platform and a proprietary novel T cell engager (nTCE) bispecific antibody platform. The Company has also established a fully integrated platform covering the key functions of biopharmaceutical development. The Company's main products include CM310, CM326 and CMG901.

Number of employees: 897

Sales per Business

HKD in Million2022Weight2023Weight Delta
Biopharmaceutical Research and Development
100.0 %
116 100.0 % 391 100.0 % +236.26%

Sales per region

HKD in Million2022Weight2023Weight Delta
Overseas
99.7 %
-- 390 99.7 % -
China
0.3 %
116 100.0 % 1 0.3 % -99.14%

Managers

Managers TitleAgeSince
Bo Chen CEO
 Chief Executive Officer 50 18-04-22
Yanrong Zhang DFI
 Director of Finance/CFO 36 20-08-31
Joy Yan CTO
 Chief Tech/Sci/R&D Officer 44 21-12-31
Changyu Wang BRD
 Director/Board Member 59 21-03-02
Qian Jia PRN
 Corporate Officer/Principal 58 18-02-28
Pak Yu Tam SEC
 Corporate Secretary - 22-03-28

Members of the board

Members of the board TitleAgeSince
Cheuk Kin Law BRD
 Director/Board Member 61 21-06-30
Yang Ke BRD
 Director/Board Member 68 21-04-02
Bo Chen CEO
 Chief Executive Officer 50 18-04-22
Changyu Wang BRD
 Director/Board Member 59 21-03-02
Gang Xu BRD
 Director/Board Member 50 18-06-20
Qi Chen BRD
 Director/Board Member 49 18-06-20
Min Chuan Wang BRD
 Director/Board Member 46 21-03-02
Yi Lun Liu BRD
 Director/Board Member 38 21-03-02
Xiao Fan Wang BRD
 Director/Board Member 68 21-04-02

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 279,735,566 156,829,644 ( 56.06 %) 0 56.06 %

Shareholders

NameEquities%Valuation
Moonshot Holdings Ltd.
27.79 %
77,751,482 27.79 % 337 M $
Boyu Capital Advisory Co. Ltd.
5.391 %
15,080,479 5.391 % 65 M $
Keymed Talent Success Trust
5.323 %
14,891,557 5.323 % 65 M $
Hillhouse Investment Management Ltd. (Invest)
4.903 %
13,714,892 4.903 % 59 M $
First Seafront Fund Management Co., Ltd.
1.567 %
4,382,500 1.567 % 19 M $
Bank of China Investment Management Co., Ltd.
1.444 %
4,039,773 1.444 % 17 M $
Zhong Ou Asset Management Co., Ltd
0.9690 %
2,710,500 0.9690 % 12 M $
Orient Securities Asset Management Co. Ltd.
0.7782 %
2,177,000 0.7782 % 9 M $
Bosera Asset Management Co., Ltd.
0.5067 %
1,417,500 0.5067 % 6 M $
Franklin Templeton Sealand Fund Management Co., Ltd.
0.3922 %
1,097,000 0.3922 % 5 M $

Company contact information

Keymed Biosciences, Inc.

Tianfu International Bio-Town No. 18 BioTown Middle Road

610219, Chengdu

+86 28 8861 0620

http://www.keymedbio.com
address Keymed Biosciences Inc.(2162)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sales per region

Ratings for Keymed Biosciences Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
32.34 CNY
Average target price
54.48 CNY
Spread / Average Target
+68.42%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
KEYMED BIOSCIENCES INC. Stock Keymed Biosciences Inc.
-28.92% 1.24B
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.26% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+1.41% 95.71B
ARGENX SE Stock argenx SE
+0.67% 22.02B
BIONTECH SE Stock BioNTech SE
-17.84% 20.9B
GENMAB A/S Stock Genmab A/S
-8.98% 17.85B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-42.83% 16.21B
BEIGENE, LTD. Stock BeiGene, Ltd.
-17.63% 15.52B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+4.55% 13.86B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+32.11% 12.04B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. 2162 Stock
  4. Company Keymed Biosciences Inc.